Zdrowie i gospodarka · 28/12/2018
FDA Announces Draft Guidance for Generic Linaclotide Oral Capsules
The FDA is releasing a draft guidance document outlining product-specific recommendations for generic linaclotide oral capsules, including bioequivalence study design requirements for abbreviated new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →